Turning Point Therapeutics, Inc. (Nasdaq – TPTX)

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Turning Point Therapeutics, Inc. (Nasdaq – TPTX) BALA CYNWYD – June 6, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Turning Point Therapeutics, Inc. (“Turning Point” or the “Company”) (Nasdaq – … Continue reading Turning Point Therapeutics, Inc. (Nasdaq – TPTX)